Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents

Fig. 1

Kaplan–Meier analysis of treatment outcomes in patients with immunoglobulin G4 (IgG4)-related sialadenitis. a Partial or complete relapse occurred in 32.5% of patients within 55 months in the regularly treated group, while in the irregularly treated group, all the patients relapsed. b The relapse-free survival curves for the groups of patients treated with or without steroid-sparing agents are not significantly different (P = 0.566). c The serologically stable survival curve shows that a serologically unstable condition occurred in 54.9% patients within 55 months in regularly treated patients

Back to article page